Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Hematologic Neoplasms 1Anxiety Disorders 1

Interventions

Cytarabine 906Cyclophosphamide 900fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 461Rituximab 431Methotrexate 420Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 287Vincristine 286Daunorubicin 284Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 178Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glutamyl Aminopeptidase × Other hematologic neoplasm × Clear all
NCT05475600 2025-03-17

APAER_H

Centre Hospitalier Régional Metz-Thionville

Phase NA Recruiting
90 enrolled
Other hematologic neoplasm

Anxiety Disorders, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡